Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim resultsSham Mailankody, Shaji Kumar, Faiz Anwer et al.|Nature Medicine|2023Cited by 239
Denosumab for Treatment of Hypercalcemia of MalignancyMimi I. Hu, Rajul K. Jain, Giuseppe Tonini et al.|The Journal of Clinical Endocrinology & Metabolism|2014Cited by 200
Denosumab for Treatment of Hypercalcemia of Malignancy in Patients with Solid Tumors or Hematological Malignancies Refractory to IV Bisphosphonates: A Single-Arm Multicenter StudyMimi I. Hu, Howard Yeh, Rasim Gucalp et al.|Blood|2011Cited by 4